Literature DB >> 28865059

Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome.

J A Gonzales Zamora1, L A Espinoza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28865059     DOI： 10.1007/s15010-017-1065-5

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  4 in total

1.  QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs.

Authors:  Olarinde Jeffrey Ogunmola; Yusuf O Oladosu; Michael A Olamoyegun
Journal:  Ann Afr Med       Date:  2015 Oct-Dec

2.  Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy.

Authors:  Monica A McArthur; Stella U Kalu; Arlen R Foulks; Ashraf M Aly; Sunil K Jain; Janak A Patel
Journal:  Pediatr Infect Dis J       Date:  2009-12       Impact factor: 2.129

3.  Blockade of HERG channels by HIV protease inhibitors.

Authors:  Blake D Anson; Joel G R Weaver; Michael J Ackerman; Omobosola Akinsete; Keith Henry; Craig T January; Andrew D Badley
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

4.  Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection.

Authors:  Santosh K Chaubey; Ashim K Sinha; Elizabeth Phillips; Darren B Russell; Henrik Falhammar
Journal:  Sex Health       Date:  2009-09       Impact factor: 2.706
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.